– 85% (p=0.0002) reduction in acute pancreatitis events, the first and only time achieved for the treatment of sHTG – – Favorable safety and tolerability profile – – sNDA submission planned by end of ...
Hosted on MSN
Olezarsen reduces levels of the blood fat, triglycerides, in patients at high cardiovascular risk: Clinical trial
Olezarsen decreased levels of triglycerides compared with placebo in patients with moderate hypertriglyceridemia and elevated cardiovascular risk, according to a late-breaking trial presented in a Hot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback